(VIANEWS) – The NASDAQ ended the session with Arcturus Therapeutics (ARCT) jumping 5.15% to $37.36 on Tuesday while NASDAQ Composite jumped 0.77% to $15,975.21.


Today’s last reported volume for Arcturus Therapeutics is 401433, 19.26% below its average volume of 497252.

Arcturus Therapeutics’s last close was $35.53, 72.61% under its 52-week high of $129.71.

Arcturus Therapeutics’s Sales

Arcturus Therapeutics’s sales growth is 625.3% for the ongoing quarter and 1814.2% for the next. The company’s growth estimates for the present quarter is a negative 72.8% and positive 6.4% for the next.

Arcturus Therapeutics’s Revenue

Year-on-year quarterly revenue growth declined by 13.8%, now sitting on 8.7M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Arcturus Therapeutics’s stock is considered to be oversold (<=20).

Arcturus Therapeutics’s Stock Yearly Top and Bottom Value

Arcturus Therapeutics’s stock is valued at $37.36 at 16:06 EST, way under its 52-week high of $129.71 and way higher than its 52-week low of $24.87.

Arcturus Therapeutics’s Moving Average

Arcturus Therapeutics’s worth is way under its 50-day moving average of $44.81 and below its 200-day moving average of $40.32.

More news about Arcturus Therapeutics (ARCT).


Please enter your comment!
Please enter your name here